Blockage of this costimulatory CD-28-CD80/86-T cell activation through abatacept-treatment decelerated atherosclerosis in ApoE3*Leiden mice acting as a common preclinical model of accelerated atherosclerosis [21]. Here, CD28 is linked to atherosclerosis.